Development
Bristol-Myers Squibb Company
BMY
$48.44
$0.631.32%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 4.66% | -2.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.66% | -2.32% | |||
| Cost of Revenue | 8.71% | -11.36% | |||
| Gross Profit | 3.47% | 0.70% | |||
| SG&A Expenses | 6.50% | 1.25% | |||
| Depreciation & Amortization | 0.98% | -0.04% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.48% | -4.01% | |||
| Operating Income | -7.22% | 5.52% | |||
| Income Before Tax | -21.67% | 14.95% | |||
| Income Tax Expenses | -143.35% | 193.12% | |||
| Earnings from Continuing Operations | -8.89% | -6.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -50.00% | |||
| Net Income | -8.61% | -6.99% | |||
| EBIT | -7.22% | 5.52% | |||
| EBITDA | -4.00% | 2.47% | |||
| EPS Basic | -7.25% | -5.36% | |||
| Normalized Basic EPS | -6.24% | 10.48% | |||
| EPS Diluted | -6.75% | -6.06% | |||
| Normalized Diluted EPS | -6.20% | 10.59% | |||
| Average Basic Shares Outstanding | -1.46% | -1.72% | |||
| Average Diluted Shares Outstanding | -1.50% | -1.81% | |||
| Dividend Per Share | 5.26% | 0.00% | |||
| Payout Ratio | 0.07% | 0.07% | |||